أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - pimobendan - capsules hard - 5 milligram - pimobendane - canine - cardiovascular

نيوزيلاندا - الإنجليزية - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - pimobendan - pimobendan 12.5 g/kg - cardiovascular agent

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - vetmedin-ca1 (pimobendan) is indicated for the delay of onset of congestive heart failure in dogs with stage b2 preclinical myxomatous mitral valve disease (2019 acvim consensus statement1 ). stage b2 preclinical myxomatous mitral valve disease (mmvd) refers to dogs with asymptomatic mmvd that have a moderate or loud mitral murmur due to mitral regurgitation and cardiomegaly. do not administer vetmedin-ca1 in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. do not administer vetmedin-ca1 to dogs with stage a or b1 preclinical mmvd (2019 acvim consensus statement) due to the risk of cardiac pathology associated with exaggerated hemodynamic responses to vetmedin-ca1.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - pimobendan 1.25 mg - vetmedin (pimobendan) is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (mmvd) or dilated cardiomyopathy (dcm). vetmedin is indicated for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. vetmedin should not be given in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. user safety warnings: not for use in humans. keep this and all medications out of reach of children. consult a physician in case of accidental ingestion by humans. animal safety warnings: keep vetmedin in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. only for use in dogs with clinical evidence of heart failure. at 3 and 5 times the recommended dosage, administered over a 6-month

إسبانيا - الإنجليزية - HMA (Heads of Medicines Agencies)

boehringer ingelheim espaÑa - pimobendan 10 mg - capsule, hard - dogs non food - pimobendane

البرتغال - الإنجليزية - HMA (Heads of Medicines Agencies)

boehringer ingelheim espaÑa - pimobendan 10 mg - capsule, hard - dogs non food - pimobendane

أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral capsule - pimobendan pyridazinone active 2.5 mg/cp - cardiovascular system - dog | bitch | castrate | puppy - congestive heart failure | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - pimobendan - capsule, hard - 5 milligram(s) - pimobendan - dogs - cardiovascular

نيوزيلاندا - الإنجليزية - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - pimobendan - pimobendan 0.75 g/litre - cardiovascular agent

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - pimobendan - solution for injection - 0.75 milligram(s)/millilitre - pimobendan